<DOC>
	<DOCNO>NCT02780414</DOCNO>
	<brief_summary>Preeclampsia ( Pre-E ) hypertensive disease pregnancy multi-system involvement usually occur second half pregnancy . Pre-E occur 5 % 7 % U.S. pregnancy , third-leading cause U.S. maternal death . Improvements current diagnostic paradigm evaluate . However , stand-alone diagnostic method emerge accurately identifies woman risk preeclampsia , warrant improvement diagnose Pre-E . This sample collection study obtain serum urine sample pregnant woman present clinical sign , symptom , condition contribute suspicion Pre-E . Samples use evaluate validate performance assay intend aid assess risk Pre-E .</brief_summary>
	<brief_title>Collection Samples From Pregnant Women Evaluation Preeclampsia ( Pre-E ) Biomarkers</brief_title>
	<detailed_description>Eligible subject provide write informed consent demographic baseline clinical data record . Collection whole blood urine sample perform one clinic visit pregnant woman carry single fetus know fetal abnormality . Interim study visit continue every 14 day [ +/- 3 day ] subject either : 1 ) reach 37 0/7 week ' gestation , 2 ) develop Pre-E , 3 ) delivers , 4 ) lose follow-up . In addition , group pregnant woman diagnose Pre-E enrol positive control case .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Pulmonary Edema</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Eligibility criterion STUDY COHORT ( CASES NEGATIVE PREE CONTROLS ) : Subject willing provide inform consent comply study procedures 18 45 year age Singleton fetus 28 0/7 36 6/7 week ' gestational age use 2014 American Congress Obstetricians Gynecologists ( ACOG ) Dating Criteria ( pregnancy start twin complicate either vanish twin syndrome fetal demise one twin 14 week , eligible inclusion ) Patient present clinical suspicion PreE base either : New onset elevate blood pressure otherwise normotensive patient , worsen hypertension patient preexist hypertension , new onset proteinuria worsen preexist proteinuria , clinical find require workup ruleout PreE . Pregnancy nonviable absence fetal cardiac activity Diagnosis PreE anticipate delivery within 24 48 hour PreE severe feature include : persistent severe hypertension ( systolic ≥160 diastolic ≥110 ; thrombocytopenia &lt; 100,000 ; liver enzymes 2x upper normal limit &gt; 70 severe persistent right upper quadrant ( RUQ ) epigastric pain , new development renal insufficiency ; pulmonary edema ; newonset persistent cerebral visual disturbance . Major fetal anomaly chromosomal aneuploidy Current dialysis kidney failure , include continuous ambulatory peritoneal dialysis Eligibility criterion POSITIVE CONTROL group : Subject willing provide inform consent comply study procedures 18 45 year age Singleton fetus 28 0/7 36 6/7 week ' gestational age use 2014 ACOG Dating Criteria ( pregnancy start twin complicate either vanish twin syndrome fetal demise one twin 14 week , eligible inclusion ) Patient diagnose PreE use 2013 ACOG guideline Pregnancy nonviable absence cardiac activity Major fetal anomaly chromosomal aneuploidy Current dialysis kidney failure , include continuous ambulatory peritoneal dialysis</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Proteinuria</keyword>
	<keyword>Thrombocytopenia</keyword>
	<keyword>Renal Insufficiency</keyword>
	<keyword>Impaired Liver Function</keyword>
	<keyword>Pulmonary Edema</keyword>
</DOC>